Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_assertion type Assertion NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_head.
- NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_assertion description "[Thus, TNFalpha antagonists and especially 5LOX inhibitors might offer new opportunities for treatment of ALS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_provenance.
- NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_assertion evidence source_evidence_literature NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_provenance.
- NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_assertion SIO_000772 15379894 NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_provenance.
- NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_assertion wasDerivedFrom befree-20140225 NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_provenance.
- NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_assertion wasGeneratedBy ECO_0000203 NP335744.RAl0ljRJdWG_G4SZMxfBDJ8t0YBumENSTb_6mqQgLiJiM130_provenance.